<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23-pharmaceuticals-13-00096">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chan</surname>
    <given-names>J.F.-W.</given-names>
   </name>
   <name>
    <surname>Yao</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Yeung</surname>
    <given-names>M.-L.</given-names>
   </name>
   <name>
    <surname>Deng</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Bao</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Jia</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Xiao</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Gao</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>P.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Treatment with lopinavir/ritonavir or interferon-Î²1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset</article-title>
  <source>J. Infect. Dis.</source>
  <year>2015</year>
  <volume>212</volume>
  <fpage>1904</fpage>
  <lpage>1913</lpage>
  <pub-id pub-id-type="doi">10.1093/infdis/jiv392</pub-id>
  <?supplied-pmid 26198719?>
  <pub-id pub-id-type="pmid">26198719</pub-id>
 </element-citation>
</ref>
